Viking Therapeutics, Inc.'s stock surged 1,500% on the promising obesity drug VK-2735, with Phase 3 trials and potential for ...

Vienna oncology research centre Research & development Vienna oncology centre opening Group photo Inauguration of Angelika ...

Gilead Sciences has come from nowhere to dominate lists of the drugmakers with the best reputations in Asia, claiming the top ...

Klick Health today announced the round two results of its $1,000,000 Klick Prize after awarding a combined $200,000 to four employee teams who contributed game-changing AI ideas for healthcare ...

Five life sciences companies are expanding their operations in Connecticut, including several that are leasing space in the ...

Boehringer is advancing the development of SZN-413 to prepare it for potential future clinical testingSZN-413 is a bi-specific antibody targeting ...

Clinical trial results shared by Boehringer Ingelheim and Insilico Medicine showed improvement in idiopathic pulmonary ...

New research from the University of Dundee shows potential breakthrough for hard to treat cancers. Experts from the ...

Spherix Global Insights has provided a different angle on AbbVie’s successful retention of Humira sales in the face of ...

Insurance companies could be required to cover asthma inhalers at no cost in New York state. Assemblywoman Jessica ...

Insurance companies could be required to cover asthma inhalers at no cost in New York state. Assemblywoman Jessica ...

Potential launches from new challengers could start in 2026 with Boehringer Ingelheim and Zealand’s survodutide. Several ...